1
|
Contro G, Sordi A, Taboni S, Citterio M, Ruaro A, De Lucia G, Pinacoli A, Carobbio ALC, Montalto N, Ramacciotti G, Grammatica A, Marioni G, Zanoletti E, Maroldi R, Piazza C, Mattavelli D, Nicolai P, Ferrari M. Prognostic Value of Anteroposterior Extension in Oral Tongue and Floor Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg 2024; 150:142-150. [PMID: 38153706 PMCID: PMC10853838 DOI: 10.1001/jamaoto.2023.3809] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2023] [Accepted: 10/29/2023] [Indexed: 12/29/2023]
Abstract
Importance The tongue and oral floor represent the most involved subsite by oral cancer, and there are no reported systems to classify anteroposterior tumor extension with prognostic effect. In other cancers, the anterior vs posterior tumor extension is a relevant prognostic factor. Objective To establish whether anterior vs posterior tumor extension may represent a prognostic factor in oral tongue and floor squamous cell carcinoma (OTFSCC). Design, Setting, and Participants This was a retrospective cohort study of patients who underwent surgery for OTFSCC from January 1, 2010, to December 31, 2021, at 2 tertiary-level academic institutions in Italy (University of Padua and University of Brescia). Patients eligible for the study had histologically proven primary OTFSCC; underwent surgery-based, curative treatment; and had available preoperative contrast-enhanced imaging. Exposures Four anatomical lines were designed to assess tumor extension: (1) chin-palate line (CPL), (2) chin-basion line, (3) Stensen duct line, and (4) lingual septum line. Preoperative imaging was re-evaluated, and tumor extension was classified as either anterior or posterior according to the lines. Main Outcomes and Measures Overall survival and time to recurrence (TTR) were evaluated according to tumor extension. These outcomes were reported as 5-year survival rates with 95% CIs. Results Of the 133 patients included, 79 (59.4%) were male, and the mean (SD) age was 62.7 (15.4) years. The 5-year TTR difference was higher for posterior vs anterior OTFSCC classified according to CPL (21.0%; 95% CI, 8.3%-33.7%), Stensen duct line (15.5%; 95% CI, 1.0%-30.0%), and lingual septum line (17.2%; 95% CI, 2.2%-32.3%). Overall survival analysis showed similar results. At the multivariable analysis on TTR, N status (adjusted hazard ratio [HR], 3.0; 95% CI, 1.2-7.1) and anteroposterior classification according to CPL (adjusted HR, 7.1; 95% CI, 0.9-54.6) were the variables associated with the highest adjusted HRs. Conclusions and Relevance In this cohort study, OTFSCC with a posterior extension to the CPL was associated with a higher risk of recurrence and death. This analysis suggests that the poor prognosis conveyed by the posterior tumor extension is independent of other relevant prognosticators except for the burden of nodal disease. This estimate is not precise and does not allow for definitive clinically important conclusions; therefore, further prospective studies are necessary to confirm these data.
Collapse
Affiliation(s)
- Giacomo Contro
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
- Technology for Health (PhD Program), Department of Information Engineering, University of Brescia, Brescia, Italy
| | - Alessandra Sordi
- Department of Otorhinolaryngology–Head and Neck Surgery, University of Brescia, Brescia, Italy
| | - Stefano Taboni
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
- Guided Therapeutics (GTx) Program International Scholarship, University Health Network (UHN), Toronto, Ontario, Canada
- Artificial Intelligence in Medicine and Innovation in Clinical Research and Methodology (PhD Program), Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Marco Citterio
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
| | - Alessandra Ruaro
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
| | - Giulia De Lucia
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
| | - Aurora Pinacoli
- Department of Otorhinolaryngology–Head and Neck Surgery, University of Brescia, Brescia, Italy
| | - Andrea Luigi Camillo Carobbio
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
| | - Nausica Montalto
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
| | - Giulia Ramacciotti
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
| | - Alberto Grammatica
- Department of Otorhinolaryngology–Head and Neck Surgery, University of Brescia, Brescia, Italy
| | - Gino Marioni
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
- Phoniatrics and Audiology Unit, Department of Neuroscience, University of Padua, Treviso, Italy
| | - Elisabetta Zanoletti
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
| | - Roberto Maroldi
- Division of Radiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy
| | - Cesare Piazza
- Department of Otorhinolaryngology–Head and Neck Surgery, University of Brescia, Brescia, Italy
| | - Davide Mattavelli
- Department of Otorhinolaryngology–Head and Neck Surgery, University of Brescia, Brescia, Italy
| | - Piero Nicolai
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
| | - Marco Ferrari
- Section of Otorhinolaryngology–Head and Neck Surgery, Department of Neuroscience, “Azienda Ospedale Università di Padova” University of Padua, Padua, Italy
- Guided Therapeutics (GTx) Program International Scholarship, University Health Network (UHN), Toronto, Ontario, Canada
| |
Collapse
|